3rd Anti-Counterfeiting Pharma 2017 - Speakers

Patrick Holt

DirectorPfizer, Global Security, EMEA

Patrick Holt is a Director in Pfizer’s Global Security group, currently responsible for counterfeit investigations and regional projects across Europe, Middle East & Africa. Prior to joining Pfizer Patrick worked in law enforcement with the Metropolitan Police Counter Terrorism Command.more

Geoffroy Bessaud

Geoffroy Bessaud is Associate Vice-President, in charge of anti-counterfeiting coordination activities at Sanofi. He started his career as a sales representative with ICI Pharmaceuticals, then joined Sanofi Pasteur and Sanofi where he became successively International Product manager, Marketing Director, Business Unit Manager, managing diverse programs in the USA, Europe, Latin America and Asia, with positions successively based in France, Italy, and Asia. He then joined Sanofi Corporate Communications as a spokesperson, also managing key global partnerships with Communications and Media Buying Agencies. Geoffroy is a Pharmacist by training and handles a MBA from HEC Business School (France).more

Peter Iles-Smith

Head of Technical – GMS IT / Design & IT Lead – SerialisationGlaxoSmithKline

Lucy Nichols

Director, Global Anti-CounterfeitingGSK

Lucy Nichols is Director, Global Anti-Counterfeiting for GSK a leading healthcare company and based at the company’s headquarters in Greater London, UK. Since obtaining her degree at Georgetown Law in Washington D.C. Lucy has focused her career primarily on devising innovative corporate strategies that encourage business stakeholder engagement to identify and address the risks associated with counterfeit products and agree upon key performance indicators. She has extensive experience in both private practice and as in-house counsel and has received industry recognition for achieving notable successful results in China.more

Patrik Merckell

Born in the French part of Switzerland, educated in Swiss School for engineers of the graphical industry, Patrik has worked in the packaging industry during his entire professional life. He has been working for Novartis since 15 years and currently holds a position of Project Manager Strategic Packaging Technology and Product Security.more

Dhermita Desai

Serialisation Programme ManagerConcordia International

Bawan A. Ahmed

Senior Pharmaceutical AssessorKurdistan Regional Government-Iraq

I’m a trained pharmacist and pharmaceutical scientist. I’m a trained pharmacist and pharmaceutical scientist. I started my career as a clinical pharmacist for a couple of years and then as pharmaceutical assessor for the Kurdistan Regional Government-Iraq. My particular area of interest is investigating the influence of temperature & humidity on stability and quality of pharmaceuticals when stored outside guidelines and specifications. In addition, designing, developing and validating novel techniques for detection of counterfeit and fake medicines. Our work has been instrumental in developing an anti-counterfeit medicines programme in Iraq, which at the end of 2012 had successfully seized 400 tonnes of counterfeit medicines of major therapeutic classes that were previously rife in Iraq’s markets. As a result of my work I received a number of internationally recognised awards; most recently The Leadership in Pharmacy Award from The Royal Pharmaceutical Society.more

Glen Hodgson

Head of HealthcareGS1 UK

Glen is Head of Healthcare for GS1 UK and a member of the GS1 Global Healthcare Leadership Team. With more than 15 years’ experience in a variety of senior commercial and operational roles within the healthcare and pharmaceutical industries, Glen has a broad range of expertise having re-engineered supply chains, developed and implemented enterprise-wide homecare strategies and formed national clinical nursing teams as well as leading multi-hundred million pound business units. Outside of GS1, Glen’s main hobby is supporting London’s greatest football team.more

Rogé Wilfrid

Director of TrainingIRACM

Wilfrid is the director of training of the International Institute against counterfeit medicines (IRACM). Since 2010, Wilfrid is the director of training of IRACM. Highly accomplished, specializing in combatting counterfeit pharmaceuticals, in particular he organized trainings for law enforcement agencies and operational exercises resulting in large counterfeit drug seizures. Former customs officer for ten years dealing with IPR matters, he joined a big pharmaceutical company in 2006 as anti-counterfeiting director.more

Ian Parsonage

Senior Director, Global Serialization ServicesPCI Pharma Services

Ian Parsonage joined PCI Pharma Services in June 2009 as head of information systems and was responsible for the introduction of a new enterprise resource planning system, coupled with significant process redesign. In March 2012, he took over the planning team and revised the planning systems and processes. Ian transferred to the role of senior director, global serialisation in June 2013 and has responsibility for all of PCI’s serialisation activity.more

Mike Isles

Executive DirectorEuropean Alliance for Access to Safe Medicines

Mike is Executive Director of the European Alliance for Access to Safe Medicines (EAASM) and the Alliance for Safe Online Pharmacy in the EU (ASOP EU) which are pan-European patient safety organisations, bringing together all concerned with eliminating falsified medicines from the supply chain as well as working to eliminate unsafe medical practices that cause patient harm.more

Bernard Naughton

Specialist Clinical PharmacistOxford University Hospitals NHS Trust

Specialist Clinical Pharmacist, Oxford University Hospitals NHS Trust and PhD Researcher, Institute of Science and Technology in Medicine, Keele University & Said Buisness School, University of Oxford (Visiting Academic). Researcher investigating the emerging issue of medicines counterfeiting. Bernard has co-authored a book chapter relating to the Falsified Medicines Directive (FMD) in “Fundamentals of EU Regulatory Affairs” and published a number of peer reviewed articles on the topic of the medicines counterfeiting, the FMD and its implication for secondary care.more

Stephen Truick

DirectorInternet Infrastructure Investigation Ltd

Stephen is a consultant internet infrastructure investigator and the owner and director of Internet Infrastructure Investigation Ltd. (www.iii3.co.uk) Stephen retired from the Metropolitan Police in 2012. His last appointment was the officer in charge of the infrastructure abuse unit, part of the National Police Central e-crime Unit (PCeU).
He is regarded as an innovator and industry / law enforcement expert in the field of Internet Infrastructure Abuse. He was also the lead infrastructure investigator at the Medicines and Healthcare products Regulatory Agency (MHRA) where he led on Internet investigations including Operation Pangea, which is the global international week of action tackling the online sale of counterfeit and illicit medicines.
Stephen now works as a consultant with many well-known companies and specialises on the identification and disruption of online organised criminal networks who are abusing the UK domain space.more

Stephen Wilkins

SecretaryChild Safe Packaging Group

Stephen Wilkins was educated at Blackrock College, Dublin and The University of Durham Business School where he obtained a Masters Degree in Business Administration. He is a Chartered Scientist, Chartered Environmentalist, Fellow of the Institute of Materials, Minerals & Mining, an elected member of the Institute of Packaging and a Fellow of the Royal Society of Arts. He was appointed Chief Executive of the Child-Safe Packaging Group upon its formation in 1995 and has driven its activities since then. The Child-Safe Packaging Group has been responsible for the design and development of numerous new child resistant packaging designs, both flexible and rigid packs. Stephen Wilkins advises manufacturers on the development of CR packaging, on the need for that packaging and in more general terms he advises clients on strategic marketing issues, usually associated with packaging and its semiotics. In addition he acts for a number of other clients in the UK undertaking marketing communications consultancy and parliamentary liaison.more

Suzanna Gamwell

Client AdvocateCREATION

Suzanna Gamwell is part of Creation Healthcare, a research consultancy that specialises in understanding online conversations between healthcare professionals. In her role as Client Advocate she works closely with client teams to understand their vision, priorities and needs, and inspires the team at Creation Healthcare to deliver the best possible customer experience and research outputs.
Before joining Creation Healthcare, Suzanna spent seven years in communications and engagement roles in the public sector, overseeing campaigns and behaviour change initiatives in the UK and Europe.more

Mark Davison

CEOBlue Sphere Health

Mark Davison is CEO of Blue Sphere Health, an international healthcare consultancy focusing on traceability and authentication of medicines. His career includes GlaxoSmithKline, contract research organisations, biotechnology companies and security vendors. Mark works with drug companies, distributors, technology suppliers and public sector organisations on preparing for FMD (EU) and DSCSA (USA) compliance and identifying added-value commercial opportunities around traceable supply chains. Mark is the author of “Pharmaceutical Anti-Counterfeiting” (Wiley, New York). www.bluespherehealth.commore

Dr Lincoln Tsang

Arnold & Porter Kaye ScholerLLP

Dr Lincoln Tsang, formerly a senior regulator qualified as a lawyer, a pharmacist with post-graduate training in toxicology and cancer pharmacology, concentrates his practice on regulatory, compliance, enforcement and public policy matters affecting the life sciences industry: pharmaceuticals, biotechnology, medical devices, in vitro diagnostic devices, cosmetics and food. He has extensive experience in advising clients in developing strategies for research and development, product life-cycle management, product acquisition, and risk and crisis management as well as internal investigations. He regularly represents clients before various regulatory bodies on matters concerning approval, advertising and promotion, manufacture, vigilance, product recall and health technology appraisal for medicines and medical devices.more

Andrew Stevens

Research Director-Supply Chain -Life SciencesGartner

Mr. Stevens helps organizations within the life sciences, medical devices, and healthcare sectors with end-to-end supply chain best practices, methodologies, maturity assessments and key insights for aligning to new modes of healthcare delivery, product differentiation and patient outcomes.
Dedicated focus of research includes :Global regulations, planning for key compliance milestones, supply chain best practices and technology capabilities for track and trace, and serialization in pharmaceuticals. Unique device identification (UDI) in the medical devices sector. Digital supply chain for life sciences industry.
Product integrity and traceability for ensuring food safety and quality in the food and beverages industry
Supply chain traceability principles and best practice across multiple industry verticalsmore

Katelen Perez

IPM Private Sector – ManagerWCO

Since 2016, I’ve joined the World Customs Organization (WCO) IPM Private Sector team as a Manager. The WCO is the only intergovernmental organization exclusively focused on Customs issues and is composed of 180 countries, representing 98% of the world trade. I am responsible for promotion of the IPM Tool amongst the Private Sector, which is the only global anti-counterfeiting tool availablemore

Julian Stutley

Joined Movilitas’ Track & Trace Team in 2014 to set up Movilitas Resourcing; providing engineering consultants to support line and site level serialisation implementation. Also manage several of our major customer relationships within the Track &Trace domain.more

Ian Haynes

Ian Haynes is an engineer with a proven record of innovative and cost effective solutions in many fields within the Pharmaceutical sector. He was previously Associate Engineering Director in the Global Engineering Technology group at AstraZeneca Pharmaceuticals where, alongside other activities, he played a key role in AZ’s Pack Coding and Security Features programme alongside Christoph Krähenbühl. As a result of this work, AstraZeneca achieved a leading position with respect to serialisation and continues to play a key role in this field today. Ian is currently a senior director of Excellis Health Solutions.more